Terms: = Prostate cancer AND DCTN1, DAP-150, 1639, ENSG00000204843, Q14203, P135, DP-150
11 results:
1. Analysis of risk factors for positive surgical margin after laparoscopic radical prostatectomy with and without neoadjuvant hormonal therapy.
Wang F; Zhang G; Tang Y; Wang Y; Li J; Xing N
Front Endocrinol (Lausanne); 2023; 14():1270594. PubMed ID: 37941905
[TBL] [Abstract] [Full Text] [Related]
2. Fever as a first presentation of castration-resistant prostate cancer: A case report.
Oh TH; Park SC
Medicine (Baltimore); 2022 Jul; 101(30):e29428. PubMed ID: 35905253
[TBL] [Abstract] [Full Text] [Related]
3. Adiposity and risk of prostate cancer death: a prospective analysis in UK Biobank and meta-analysis of published studies.
Perez-Cornago A; Dunneram Y; Watts EL; Key TJ; Travis RC
BMC Med; 2022 May; 20(1):143. PubMed ID: 35509091
[TBL] [Abstract] [Full Text] [Related]
4. Multicenter External Validation of a Nomogram for Predicting Positive prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with prostate cancer Recurrence.
Bianchi L; Castellucci P; Farolfi A; Droghetti M; Artigas C; Leite J; Corona P; Shagera QA; Moreira R; González C; Queiroz M; de Galiza Barbosa F; Schiavina R; Deandreis D; Fanti S; Ceci F
Eur Urol Oncol; 2023 Feb; 6(1):41-48. PubMed ID: 34933814
[TBL] [Abstract] [Full Text] [Related]
5. Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer.
Huber M; Kepesidis KV; Voronina L; Fleischmann F; Fill E; Hermann J; Koch I; Milger-Kneidinger K; Kolben T; Schulz GB; Jokisch F; Behr J; Harbeck N; Reiser M; Stief C; Krausz F; Zigman M
Elife; 2021 Oct; 10():. PubMed ID: 34696827
[TBL] [Abstract] [Full Text] [Related]
6. prostate cancer: performance characteristics of combined T₂W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion.
Lawrence EM; Tang SY; Barrett T; Koo B; Goldman DA; Warren AY; Axell RG; Doble A; Gallagher FA; Gnanapragasam VJ; Kastner C; Sala E
Eur Radiol; 2014 Jul; 24(7):1497-505. PubMed ID: 24744197
[TBL] [Abstract] [Full Text] [Related]
7. HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.
Olson BM; Frye TP; Johnson LE; Fong L; Knutson KL; Disis ML; McNeel DG
Cancer Immunol Immunother; 2010 Jun; 59(6):943-53. PubMed ID: 20140431
[TBL] [Abstract] [Full Text] [Related]
8. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract] [Full Text] [Related]
9. Docetaxel plus prednisone versus mitoxantrone plus prednisone for metastatic hormone-refractory prostate cancer in Chinese patients: experience of a single center.
Zhang HL; Ye DW; Yao XD; Dai B; Zhang SL; Shen YJ; Zhu Y; Zhang W
Urol Int; 2007; 79(4):307-11. PubMed ID: 18025847
[TBL] [Abstract] [Full Text] [Related]
10. Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.
Nilsson S; Franzén L; Parker C; Tyrrell C; Blom R; Tennvall J; Lennernäs B; Petersson U; Johannessen DC; Sokal M; Pigott K; Yachnin J; Garkavij M; Strang P; Harmenberg J; Bolstad B; Bruland OS
Lancet Oncol; 2007 Jul; 8(7):587-94. PubMed ID: 17544845
[TBL] [Abstract] [Full Text] [Related]
11. [Application and limitation of neoadjuvant hormonal therapy for prostate cancer].
Demura T; Shinohara N; Nonomura K; Koyanagi T
Nihon Rinsho; 1998 Aug; 56(8):2150-6. PubMed ID: 9750525
[TBL] [Abstract] [Full Text] [Related]
